Ekso Bionics Holdings Inc
(EKSO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,945 | -9,760 | -4,115 | -33,769 | -13,614 |
| Depreciation Amortization | 625 | 400 | 190 | 917 | 699 |
| Accounts receivable | -636 | -845 | 94 | -1,000 | -1,372 |
| Accounts payable and accrued liabilities | 1,365 | 1,523 | 681 | -716 | -422 |
| Other Working Capital | -21 | 107 | -297 | 230 | -1,418 |
| Other Operating Activity | 530 | 113 | -381 | 19,331 | 3,831 |
| Operating Cash Flow | $-13,082 | $-8,462 | $-3,828 | $-15,007 | $-12,296 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -962 | -559 | -281 | -1,487 | -917 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 104 |
| Investing Cash Flow | $-962 | $-559 | $-281 | $-1,487 | $-813 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -40 | -22 | -11 | -2,596 | -2,547 |
| Common Stock Issued | 132 | 104 | 63 | 43,475 | 22,027 |
| Financing Cash Flow | $92 | $82 | $52 | $40,879 | $19,480 |
| Beginning Cash Position | 25,190 | 25,190 | 25,190 | 805 | 805 |
| End Cash Position | 11,238 | 16,251 | 21,133 | 25,190 | 7,176 |
| Net Cash Flow | $-13,952 | $-8,939 | $-4,057 | $24,385 | $6,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,082 | -8,462 | -3,828 | -15,007 | -12,296 |
| Capital Expenditure | -962 | -559 | -281 | -1,487 | -917 |
| Free Cash Flow | -14,044 | -9,021 | -4,109 | -16,494 | -13,213 |